The global tulathromycin market has an expansive layout in North America. Regardless of lodging just 5% of the population, the area holds a considerable portion of the general market. The US stands firm on a prevailing foothold in the region and the international market. The cattle population in the US decreased in 2019 due to respiratory diseases. Hence, the need for tulathromycin spurred in the market. Its demand is also increasing in Europe as it is widely used to treat respiratory infections in cattle and pigs.